drugset / Trial / NCT00264303

CUTE (Chronic Urticaria Treatment Evaluation)

NCT00264303

Phase 4 Completed 886 enrolled UCB Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

A study to compare the clinical efficacy and safety of Levocetirizine vs. Desloratadine in patients suffering from Chronic Idiopathic Urticaria (CIU) measured by the mean pruritus severity score over the first week of treatment

Timeline

Start
2005-12
Primary completion
2007-01
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Desloratadine Small molecule 5 mg Oral
Subject Levocetirizine Unknown 5 mg Oral